Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Current Hematologic Malignancy Reports|July 3, 2023
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative DiseasesAndrea Duminuco, Elena Torre, Giuseppe A Palumbo, et al.Leukemia & Lymphoma|July 2, 2025
Recommendations for best management of polycythemia vera in Italy: a Delphi consensus statementMassimiliano Bonifacio, Massimo Breccia, Paola Guglielmelli, et al.Cancers|January 11, 2024
ACVR1: A Novel Therapeutic Target to Treat Anemia in MyelofibrosisAndrea Duminuco, Helen T Chifotides, Sebastiano Giallongo, et al.Annals of Hematology|July 1, 2026
A systematic review of 47 published cases of extramedullary hematopoiesis in myelofibrosis: clinical patterns, treatment responses, and prognostic implicationsAndrea Duminuco, Veronica Vecchio, Giulio Lavenia, et al.Frontiers in Oncology|August 8, 2024
Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectivesMassimo Breccia, Francesca Palandri, Nicola Polverelli, et al.Current Hematologic Malignancy Reports|May 3, 2025
Emerging Therapeutic Approaches for Anemia in MyelofibrosisHelen T Chifotides, Andrea Duminuco, Elena Torre, et al.Hematology, Transfusion and Cell Therapy|September 17, 2023
Evaluation of erythrocytapheresis compared to phlebotomy in polycythaemia vera patientsSergio Cabibbo, Giovanna Oriella Manenti, Agostino Antolino, et al.Leukemia & Lymphoma|March 5, 2003
Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomasGiuseppe Milone, Francesco Di Raimondo, Felicina Li Gioi, et al.Journal of Clinical Medicine|December 23, 2022
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life SettingAndrea Duminuco, Antonella Nardo, Bruno Garibaldi, et al.Frontiers in Oncology|May 21, 2019
The Role of New Technologies in Myeloproliferative NeoplasmsGiuseppe A Palumbo, Stefania Stella, Maria Stella Pennisi, et al.Pageof 12